Table 1.
No Iso Infusion |
7-d Iso Infusion |
p Value |
|||||
---|---|---|---|---|---|---|---|
Con (28) | C1C2 (29) | Con (6) | C1C2 (6) | Interaction | Iso | Gene | |
Heart rate, beats/min | 530 ± 10 | 521 ± 17 | 508 ± 7 | 499 ± 3 | 0.99 | 0.31 | 0.68 |
End-diastolic dimension, mm | 3.9 ± 0.1 | 4.0 ± 0.1 | 4.0 ± 0.2 | 3.9 ± 0.1 | 0.56 | 0.91 | 0.88 |
End-systolic dimension, mm | 2.5 ± 0.1 | 2.6 ± 0.1 | 2.7 ± 0.2 | 2.7 ± 0.1 | 0.68 | 0.25 | 0.90 |
% Fractional shortening | 38 ± 2 | 36 ± 2 | 32 ± 2 | 31 ± 2 | 0.85 | 0.04 | 0.70 |
Values are mean ± SE; (group size), p values are from 2-way ANOVA.
7-day Iso = 7 days continuous isoproterenol infusion; C1C2 = transgenic mice with cardiac-directed C1C2 expression; Con = transgene-negative sibling mice used as controls.